SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (1098)7/31/1997 4:37:00 PM
From: margie   of 6136
 
From Briefing Com: After the Close

Agouron Pharmaceuticals (AGPH) 95 3/4 -1 15/16: --UPDATE-- pharmaceutical concern posts a fiscal 4Q profit of $0.17 a share, before charges, vs year-ago loss of $0.17 a share; company lost $0.76 a share after charge; the First Call mean estimate called for a loss of $0.12 a share; revenues rose 113.5% to $60.83 mln.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext